Mesenchymal stem cell therapy in diabetic foot ulcer: An updated comprehensive review.

Helal F HettaAlaa ElsaghirVictor Coll SijercicMahad S AkhtarSayed A GadAvinash MosesMahlet S ZelekeFawaz E AlanaziAbdulrahman K AhmedYasmin N Ramadan

Published in: Health science reports (2024)

The incorporation of MSCs in the management of DFU highlights their potential as a feasible therapeutic strategy. Establishing a comprehensive understanding of the complex relationship between DFU pathophysiology, MSC therapies, and related obstacles is essential for optimizing therapy outcomes and maximizing patient benefits.

Keyphrases

mesenchymal stem cells
bone marrow
type diabetes
cell therapy
metabolic syndrome
adipose tissue
risk assessment
insulin resistance